BIOTECH STOCKS Drug stocks rise

BIOTECH STOCKS Drug stocks rise; Atherogenics slides on testing woes
MarketWatch - USA Late Friday, the biotech group said that after consulting
with regulators, it was ceasing testing of AGI-1067 in 300 mg doses due to
concerns over liver ...

http://www.marketwatch.com/news/story/drug-stocks-rise-atherogenics-slides/
story.aspx?guid=%7BCCC1097C-6C7C-419D-8AFD-2DCBF905F090%7D

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.marketwatch.com/news/story
/drug-stocks-rise-atherogenics-slides/story.aspx%3Fguid%3D%257BCCC1097C-6C7C
-419D-8AFD-2DCBF905F090%257D


Biotech News
AZhttp, Inc.
Biotechnology Marketing